Literature DB >> 22589558

Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.

C Roger White1, Geeta Datta, Amanda K W Buck, Manjula Chaddha, Gautam Reddy, Landon Wilson, Mayakonda N Palgunachari, Mohammad Abbasi, G M Anantharamaiah.   

Abstract

Myeloperoxidase (MPO)-derived hypochlorous acid induces changes in HDL function via redox modifications at the level of apolipoprotein A-I (apoA-I). As 4F and apoA-I share structural and functional properties, we tested the hypothesis that 4F acts as a reactive substrate for hypochlorous acid (HOCl). 4F reduced the HOCl-mediated oxidation of the fluorescent substrate APF in a concentration-dependent manner (ED(50) ∼ 56 ± 3 μM). This reaction induced changes in the physical properties of 4F. Addition of HOCl to 4F at molar ratios ranging from 1:1 to 3:1 reduced 4F band intensity on SDS-PAGE gels and was accompanied by the formation of a higher molecular weight species. Chromatographic studies showed a reduction in 4F peak area with increasing HOCl and the formation of new products. Mass spectral analyses of collected fractions revealed oxidation of the sole tryptophan (Trp) residue in 4F. 4F was equally susceptible to oxidation in the lipid-free and lipid-bound states. To determine whether Trp oxidation influenced its apoA-I mimetic properties, we monitored effects of HOCl on 4F-mediated lipid binding and ABCA1-dependent cholesterol efflux. Neither property was altered by HOCl. These results suggest that 4F serves as a reactive substrate for HOCl, an antioxidant response that does not influence the lipid binding and cholesterol effluxing capacities of the peptide.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22589558      PMCID: PMC3540838          DOI: 10.1194/jlr.M026278

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  44 in total

1.  Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.

Authors:  G Datta; M Chaddha; S Hama; M Navab; A M Fogelman; D W Garber; V K Mishra; R M Epand; R F Epand; S Lund-Katz; M C Phillips; J P Segrest; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

2.  Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.

Authors:  Mohamad Navab; G M Anantharamaiah; Susan Hama; David W Garber; Manjula Chaddha; Greg Hough; Roger Lallone; Alan M Fogelman
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

3.  Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.

Authors:  S Baldus; J P Eiserich; A Mani; L Castro; M Figueroa; P Chumley; W Ma; A Tousson; C R White; D C Bullard; M L Brennan; A J Lusis; K P Moore; B A Freeman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds.

Authors:  D I Pattison; M J Davies
Journal:  Chem Res Toxicol       Date:  2001-10       Impact factor: 3.739

5.  Association between myeloperoxidase levels and risk of coronary artery disease.

Authors:  R Zhang; M L Brennan; X Fu; R J Aviles; G L Pearce; M S Penn; E J Topol; D L Sprecher; S L Hazen
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

6.  Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein.

Authors:  A C Carr; T Tijerina; B Frei
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

7.  Macrophage activation includes high intracellular myeloperoxidase activity.

Authors:  Maria Rita Rodrigues; Dunia Rodriguez; Momtchilo Russo; Ana Campa
Journal:  Biochem Biophys Res Commun       Date:  2002-04-12       Impact factor: 3.575

Review 8.  Hypochlorite-induced oxidation of amino acids, peptides and proteins.

Authors:  C L Hawkins; D I Pattison; M J Davies
Journal:  Amino Acids       Date:  2003-07-29       Impact factor: 3.520

9.  Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.

Authors:  Gunther Marsche; Astrid Hammer; Olga Oskolkova; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

10.  Transmembrane helix dynamics of bacterial chemoreceptors supports a piston model of signalling.

Authors:  Benjamin A Hall; Judith P Armitage; Mark S P Sansom
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.779

View more
  8 in total

1.  The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.

Authors:  C Roger White; Geeta Datta; Landon Wilson; Mayakonda N Palgunachari; G M Anantharamaiah
Journal:  Chem Phys Lipids       Date:  2019-01-29       Impact factor: 3.329

Review 2.  Apolipoprotein A-I mimetics.

Authors:  Srinivasa T Reddy; Mohamad Navab; Gattadahalli M Anantharamaiah; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

3.  L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; Edlue M Tabengwa; C Roger White; Mayakonda N Palgunachari; G M Anantharamaiah; Himanshu Gupta
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.

Authors:  Su Duy Nguyen; Katariina Maaninka; Jani Lappalainen; Katariina Nurmi; Jari Metso; Katariina Öörni; Mohamad Navab; Alan M Fogelman; Matti Jauhiainen; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

5.  High-Resolution Structural Studies Elucidate Antiatherogenic and Anti-Inflammatory Properties of Peptides Designed to Mimic Amphipathic α-Helical Domains of Apolipoprotein A-I.

Authors:  Vinod K Mishra; Gattadahalli M Anantharamaiah
Journal:  Nat Prod Commun       Date:  2019-05-28       Impact factor: 1.496

6.  Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; William E Grizzle; Vinod K Mishra; Jaideep Honavar; Silvio H Litovsky; Mayakonda N Palgunachari; C Roger White; G M Anantharamaiah; Himanshu Gupta
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

7.  Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells.

Authors:  Kouji Yano; Ryunosuke Ohkawa; Megumi Sato; Akira Yoshimoto; Naoya Ichimura; Takahiro Kameda; Tetsuo Kubota; Minoru Tozuka
Journal:  J Lipids       Date:  2016-11-09

Review 8.  Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies.

Authors:  Gunther Marsche; Julia T Stadler; Julia Kargl; Michael Holzer
Journal:  Antioxidants (Basel)       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.